Fast, qualitative analysis of p53 phosphorylation by protein kinases.
Chène
P
P
Oncology Department, Novartis, Basel, Switzerland. patrick.chene@pharma.novartis.com
D000818:Animals; D001709:Biotechnology; D047390:Casein Kinase II; D020134:Catalytic Domain / Q000235:genetics; D016158:Genes, p53; D066298:In Vitro Techniques; D009154:Mutation; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D011817:Rabbits; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012156:Reticulocytes / Q000378:metabolism; D013379:Substrate Specificity; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*
D011994:Recombinant Proteins; D016159:Tumor Suppressor Protein p53; D047390:Casein Kinase II; D017346:Protein Serine-Threonine Kinases